-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2023.
- Protalix BioTherapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 73.3M shares, a 11.9% decline year-over-year.
- Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 82.4M shares, a 70% increase from 2022.
- Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 48.5M shares, a 9.81% increase from 2021.
- Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 44.1M shares, a 51.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)